BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 24053209)

  • 1. Hematological malignancies: role of miRNAs and their in silico aspects.
    Omer A; Yadav NK; Singh P; Singh RK
    Expert Rev Anticancer Ther; 2013 Sep; 13(9):1121-33. PubMed ID: 24053209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs in hematological malignancies.
    Lawrie CH
    Blood Rev; 2013 May; 27(3):143-54. PubMed ID: 23623930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of microRNAs in hematological malignancies.
    Fatica A; Bozzoni I
    Expert Rev Hematol; 2009 Aug; 2(4):415-23. PubMed ID: 21082946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs in myeloid malignancies.
    Gordon JE; Wong JJ; Rasko JE
    Br J Haematol; 2013 Jul; 162(2):162-76. PubMed ID: 23679825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-binding site polymorphisms in hematological malignancies.
    Dzikiewicz-Krawczyk A
    J Hematol Oncol; 2014 Nov; 7():83. PubMed ID: 25421940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The research progress of circular RNAs in hematological malignancies.
    Ji T; Chen Q; Tao S; Shi Y; Chen Y; Shen L; Wang C; Yu L
    Hematology; 2019 Dec; 24(1):727-731. PubMed ID: 31581903
    [No Abstract]   [Full Text] [Related]  

  • 8. MicroRNA polymorphisms as markers of risk, prognosis and treatment response in hematological malignancies.
    Dzikiewicz-Krawczyk A
    Crit Rev Oncol Hematol; 2015 Jan; 93(1):1-17. PubMed ID: 25217091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.
    Wang LQ; Liang R; Chim CS
    Expert Rev Mol Diagn; 2012 Sep; 12(7):755-65. PubMed ID: 23153241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential therapeutic applications of miRNA-based technology in hematological malignancies.
    Barbarotto E; Calin GA
    Curr Pharm Des; 2008; 14(21):2040-50. PubMed ID: 18691114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of copy number variations of BS69 in multiple types of hematological malignancies.
    Yang H; Zhang C; Zhao X; Wu Q; Fu X; Yu B; Shao Y; Guan M; Zhang W; Wan J; Huang X
    Ann Hematol; 2010 Oct; 89(10):959-64. PubMed ID: 20425112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between microRNA-155 and hematological malignancies].
    Xue H; Hua LM; Luo JM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):810-4. PubMed ID: 23815946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
    Xie L; Jing R; Qi J; Lin Z; Ju S
    Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miRNAs in acute myeloid leukemia.
    Liao Q; Wang B; Li X; Jiang G
    Oncotarget; 2017 Jan; 8(2):3666-3682. PubMed ID: 27705921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research Progress of microRNAs and human hematological diseases - review].
    Meng DM; Miao ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):979-83. PubMed ID: 18718104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in cancer: personalizing diagnosis and therapy.
    Nana-Sinkam SP; Fabbri M; Croce CM
    Ann N Y Acad Sci; 2010 Oct; 1210():25-33. PubMed ID: 20973796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in Autoimmunity and Hematological Malignancies.
    Di Marco M; Ramassone A; Pagotto S; Anastasiadou E; Veronese A; Visone R
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30322050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic regulation of miRNA genes in acute leukemia.
    Agirre X; Martínez-Climent JÁ; Odero MD; Prósper F
    Leukemia; 2012 Mar; 26(3):395-403. PubMed ID: 22143672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioinformatics prioritization of SNPs perturbing microRNA regulation of hematological malignancy-implicated genes.
    Ghaedi H; Bastami M; Zare-Abdollahi D; Alipoor B; Movafagh A; Mirfakhraie R; Omrani MD; Masotti A
    Genomics; 2015 Dec; 106(6):360-6. PubMed ID: 26520014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.